An overview of trials on heart, kidney, liver, joints, lungs, mood and psoriasis, with notes on where evidence is still early or unproven.
Recap by typeshit. Full story at Yahoo Health.
A retrospective cohort checks whether retinal disease started or worsened more in established users than in people never on either drug, plus a regional NAION review.
24:34
An animated explainer walking through what semaglutide does in the body, from appetite signals in the brain to digestion and blood sugar control.
In rats and minipigs, doses too small to cut weight still reduced heart scarring and stiffness tied to a common heart failure type, researchers report.
German researchers made synthetic versions of peptides from axolotl skin mucus, and some slowed the growth of MRSA, the drug-resistant bacteria.
GoodRx explains how Wegovy fits into menopause weight management and what to ask a doctor about before considering it.
Doctor Devine says more patients on GLP-1 weight loss drugs are coming in with concerns, though the specific issue is cut off.
Loading…